This product is available for US customers only
Product

ZEISS CT LUCIA 602

Reliable monofocal hydrophobic, 3-piece-IOL performance

The CT LUCIA® 602 is an aspheric 3-piece IOL from ZEISS. Featuring highly stable PVDF haptics designed to ensure IOL stability in the capsular bag1,2. CT LUCIA 3-piece IOLs from ZEISS are glistening-free3  and have a 360° square edge design for a low PCO rate4.

  • High corrected visual acuity5
  • Good refractive results5
  • Low inflammatory reaction5

ZEISS CT LUCIA 602

Monofocal, aspheric IOL

  • Monofocal, aspheric
  • PVDF haptics designed for good capsular bag stability1,2 and to eliminate capsular bag stretching.
  • 360° square-edge design to reduce PCO.
  • Featuring the patented ZO Asphericity Concept (ZO: ZEISS Optic)  designed to compensate for a range of aberrations, providing better image quality in real-life conditions.

High corrected visual acuity5

The high stability of the lens in the capsular bag supports good visual outcomes after surgery.

Good refractive results5

IOL stability in the capsular bag, in conjunction with a low amount of post-surgery complications, facilitates good refractive results.

Low inflammatory reaction5

The safety of the lens after implantation proved to be reassuring with low rates of post-surgery events. Inflammatory reaction were minimal and mostly related to the procedure itself and not to the IOL.

Handling instruction video

  • ZEISS CT LUCIA 602

Downloads

    • CT LUCIA 602 Datasheet US

      Pages: 4
      File size: 833 KB
    • CT LUCIA 602 Handling Instructions US

      Pages: 2
      File size: 348 KB

Specifications

ZEISS CT LUCIA 602

Optic Design

Monofocal, aspheric (aberration correcting)

Material

Hydrophobic acrylic with Polyvinylidene fluoride (PVDF) monofilament haptics   

Optic Diameter
6.0 mm
Total Diameter
13.0 mm
Haptic Angulation
Lens Design
Three-piece
Incision Size
2.8 mm

Company Labeled A-Constant6

117.7   

Diopter Range
From +4.0 to +34.0 D, 0.5 D increments

ACD6

4.8   

Abbe

51

Implantation in

Capsular bag

Injector / Cartridge Set

ZEISS R28 IOL Delivery System with ZEISS Z28 Cartridge IOL Delivery System for diopter range +4.0 to +34.0 D   

Get in touch with us!

Form is loading...

Personal contact information

If you want to have more information on data processing at ZEISS please refer to our data privacy notice

  • 1

    EC-3 Pivotal Clinical Study (FDA IDE) (354 eyes): tilt 0 (0%), decentration 1 (0.3%) at 12M FU

  • 2

    EC-3 Pivotal Clinical Study (FDA IDE) (101 eyes): tilt 0 (0%), decentration 0 (0%) at 3Y+ FU

  • 3

    EC-3 Pivotal Clinical Study (FDA IDE): no glistenings (0%) at 12M (354 eyes)+ over 3.7Y FU (101 eyes).

  • 4

    EC-3 Pivotal Clinical Study (FDA IDE) (354 eyes): 22,3% minimal PCO, 4,8% moderate PCO, 0,6% dense PCO up to 12M FU.

  • 5

    EC-3 Pivotal Clinical Study (FDA IDE study): n=324, 12 month

  • 6

    For optimized A Constants and ACD Constants refer to IOLCon: https://iolcon.org/lensesTable.php. Last retrieved 2019-02-28